Outsourcing Outlook

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-09-02-2002, Volume 26, Issue 9

The author discusses the potential effect on CROs of pending major-pharma mergers and consolidations.

Related Content:

Bio/Pharma BusinessAnalyticsOutsourcingManufacturingOutsourcing OutlookContract Manufacturing, GeneralPharmaceutical Technology-09-02-2002
Increasing mRNA Product Stability with Lyophilization
Bristol Myers Squibb to Access Cellares' Cell Therapy Manufacturing Platform in New $380 Million CAR-T Cell Therapy Deal
INTERPHEX 2024: Implementing Contamination Control Strategies in Cell and Gene Therapy Facilities